Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hilary Aroke
Guideline-Concordant Treatment Among Elderly Women With HER2-Positive Metastatic Breast Cancer in the United States
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Related publications
Estimated Life-Years Saved in Women With HER2-Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Oncofertility Counselling in Premenopausal Women With HER2-positive Breast Cancer
Oncotarget
Oncology
New Developments in the Treatment of HER2-positive Breast Cancer
Breast Cancer: Targets and Therapy
Oncology
Therapy Landscape in Patients With Metastatic HER2-Positive Breast Cancer: Data From the PRAEGNANT Real-World Breast Cancer Registry
Cancers
Cancer Research
Oncology
Optimal Treatment of Early Stage HER2-positive Breast Cancer
Cancer
Cancer Research
Oncology
Current Neoadjuvant Treatment Options for HER2 Positive Breast Cancer
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Phase II Trial of Fulvestrant With Metronomic Capecitabine for Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Patient With Metastatic Breast Cancer, HER2-positive, Trastuzumab- And Pertuzumab-Resistant Responding to Lapatinib
AboutOpen
Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
